nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—skin cancer—salivary gland cancer	0.916	1	CtDrD
Vemurafenib—BRAF—Disease—JAG1—salivary gland cancer	3.5e-05	0.000416	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGFR4—salivary gland cancer	3.48e-05	0.000415	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	3.46e-05	0.000412	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—MAP2K2—salivary gland cancer	3.44e-05	0.000409	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FBXW7—salivary gland cancer	3.43e-05	0.000408	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NUP62—salivary gland cancer	3.39e-05	0.000403	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	3.36e-05	0.0004	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	3.36e-05	0.0004	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—salivary gland cancer	3.35e-05	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—PIK3CA—salivary gland cancer	3.3e-05	0.000393	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF16—salivary gland cancer	3.3e-05	0.000393	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PHGDH—salivary gland cancer	3.3e-05	0.000392	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ISYNA1—salivary gland cancer	3.29e-05	0.000392	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AQP1—salivary gland cancer	3.27e-05	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—salivary gland cancer	3.26e-05	0.000389	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF16—salivary gland cancer	3.26e-05	0.000388	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—HRAS—salivary gland cancer	3.25e-05	0.000386	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF16—salivary gland cancer	3.23e-05	0.000385	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—HRAS—salivary gland cancer	3.19e-05	0.00038	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	3.17e-05	0.000378	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—PIK3CA—salivary gland cancer	3.17e-05	0.000377	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MC3R—salivary gland cancer	3.16e-05	0.000376	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—PIK3CA—salivary gland cancer	3.15e-05	0.000376	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—PIK3CA—salivary gland cancer	3.14e-05	0.000374	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NUP62—salivary gland cancer	3.13e-05	0.000372	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—PIK3CA—salivary gland cancer	3.12e-05	0.000372	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—PIK3CA—salivary gland cancer	3.11e-05	0.00037	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	3.1e-05	0.00037	CbGpPWpGaD
Vemurafenib—RAF1—Disease—VCAN—salivary gland cancer	3.1e-05	0.000369	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NUP62—salivary gland cancer	3.1e-05	0.000369	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—VCAN—salivary gland cancer	3.08e-05	0.000366	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—HRAS—salivary gland cancer	3.06e-05	0.000364	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ST3GAL4—salivary gland cancer	3.04e-05	0.000362	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MAP2K2—salivary gland cancer	3.04e-05	0.000361	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	3.01e-05	0.000358	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	2.99e-05	0.000356	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—salivary gland cancer	2.95e-05	0.000351	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—HRAS—salivary gland cancer	2.93e-05	0.000349	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	2.92e-05	0.000348	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—PIK3CA—salivary gland cancer	2.92e-05	0.000348	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	2.92e-05	0.000348	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—HRAS—salivary gland cancer	2.92e-05	0.000347	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	2.9e-05	0.000346	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—HRAS—salivary gland cancer	2.9e-05	0.000346	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—PIK3CA—salivary gland cancer	2.9e-05	0.000345	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FOXO3—salivary gland cancer	2.89e-05	0.000344	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—HRAS—salivary gland cancer	2.89e-05	0.000344	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AQP1—salivary gland cancer	2.88e-05	0.000343	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—PIK3CA—salivary gland cancer	2.88e-05	0.000343	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—HRAS—salivary gland cancer	2.88e-05	0.000342	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	2.87e-05	0.000342	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAML2—salivary gland cancer	2.87e-05	0.000341	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—PIK3CA—salivary gland cancer	2.86e-05	0.00034	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MAML2—salivary gland cancer	2.83e-05	0.000337	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—PTEN—salivary gland cancer	2.82e-05	0.000336	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NOTCH1—salivary gland cancer	2.82e-05	0.000335	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MAML2—salivary gland cancer	2.81e-05	0.000334	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—PIK3CA—salivary gland cancer	2.76e-05	0.000329	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DTX4—salivary gland cancer	2.76e-05	0.000329	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	2.75e-05	0.000328	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	2.72e-05	0.000324	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—HRAS—salivary gland cancer	2.72e-05	0.000323	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	2.71e-05	0.000322	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—HRAS—salivary gland cancer	2.71e-05	0.000322	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—HRAS—salivary gland cancer	2.71e-05	0.000322	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MARCKS—salivary gland cancer	2.68e-05	0.000319	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—HRAS—salivary gland cancer	2.68e-05	0.000319	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—HRAS—salivary gland cancer	2.66e-05	0.000317	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	2.66e-05	0.000317	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	2.66e-05	0.000316	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—HRAS—salivary gland cancer	2.65e-05	0.000315	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGFR4—salivary gland cancer	2.61e-05	0.000311	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NUP62—salivary gland cancer	2.6e-05	0.000309	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	2.59e-05	0.000308	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—VCAN—salivary gland cancer	2.58e-05	0.000307	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FBXW7—salivary gland cancer	2.57e-05	0.000306	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—HRAS—salivary gland cancer	2.56e-05	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CREBBP—salivary gland cancer	2.55e-05	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—CREBBP—salivary gland cancer	2.5e-05	0.000298	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	2.5e-05	0.000298	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PYGB—salivary gland cancer	2.49e-05	0.000297	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—HRAS—salivary gland cancer	2.45e-05	0.000292	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—JAG1—salivary gland cancer	2.45e-05	0.000292	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	2.45e-05	0.000291	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGFR4—salivary gland cancer	2.44e-05	0.00029	CbGpPWpGaD
Vemurafenib—RAF1—Disease—JAG1—salivary gland cancer	2.42e-05	0.000288	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGFR4—salivary gland cancer	2.41e-05	0.000287	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FBXW7—salivary gland cancer	2.4e-05	0.000286	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—JAG1—salivary gland cancer	2.4e-05	0.000285	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	2.4e-05	0.000285	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGFR4—salivary gland cancer	2.39e-05	0.000284	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FBXW7—salivary gland cancer	2.37e-05	0.000282	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MAP2K2—salivary gland cancer	2.36e-05	0.000281	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FBXW7—salivary gland cancer	2.35e-05	0.00028	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	2.32e-05	0.000276	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	2.3e-05	0.000274	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NUP62—salivary gland cancer	2.28e-05	0.000272	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF16—salivary gland cancer	2.28e-05	0.000272	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—VCAN—salivary gland cancer	2.27e-05	0.00027	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	2.26e-05	0.000269	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CREBBP—salivary gland cancer	2.26e-05	0.000268	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MARCKS—salivary gland cancer	2.22e-05	0.000264	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.17e-05	0.000258	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FOXO3—salivary gland cancer	2.17e-05	0.000258	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CDH1—salivary gland cancer	2.15e-05	0.000256	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.15e-05	0.000256	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PYGB—salivary gland cancer	2.06e-05	0.000245	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PHGDH—salivary gland cancer	2.03e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	2.03e-05	0.000241	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FOXO3—salivary gland cancer	2.02e-05	0.000241	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FOXO3—salivary gland cancer	2e-05	0.000238	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—PIK3CA—salivary gland cancer	1.99e-05	0.000237	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAML2—salivary gland cancer	1.98e-05	0.000236	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FOXO3—salivary gland cancer	1.98e-05	0.000236	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ST3GAL4—salivary gland cancer	1.96e-05	0.000233	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—MAP2K2—salivary gland cancer	1.94e-05	0.00023	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOTCH1—salivary gland cancer	1.93e-05	0.00023	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.89e-05	0.000225	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—HRAS—salivary gland cancer	1.88e-05	0.000224	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MARCKS—salivary gland cancer	1.88e-05	0.000223	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	1.87e-05	0.000223	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—HRAS—salivary gland cancer	1.84e-05	0.000219	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AQP1—salivary gland cancer	1.78e-05	0.000212	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	1.78e-05	0.000212	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MAP2K2—salivary gland cancer	1.77e-05	0.00021	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CREBBP—salivary gland cancer	1.75e-05	0.000209	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PYGB—salivary gland cancer	1.74e-05	0.000208	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EP300—salivary gland cancer	1.74e-05	0.000207	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—EP300—salivary gland cancer	1.71e-05	0.000203	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—JAG1—salivary gland cancer	1.69e-05	0.000202	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGFR4—salivary gland cancer	1.69e-05	0.000201	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PHGDH—salivary gland cancer	1.68e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—HRAS—salivary gland cancer	1.67e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FBXW7—salivary gland cancer	1.66e-05	0.000198	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAP2K2—salivary gland cancer	1.65e-05	0.000197	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MAP2K2—salivary gland cancer	1.63e-05	0.000194	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MAP2K2—salivary gland cancer	1.62e-05	0.000193	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	1.62e-05	0.000192	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.61e-05	0.000192	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PTEN—salivary gland cancer	1.61e-05	0.000192	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PTEN—salivary gland cancer	1.55e-05	0.000184	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.54e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EP300—salivary gland cancer	1.54e-05	0.000183	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AQP1—salivary gland cancer	1.47e-05	0.000175	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MARCKS—salivary gland cancer	1.45e-05	0.000172	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PHGDH—salivary gland cancer	1.42e-05	0.000169	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NUP62—salivary gland cancer	1.41e-05	0.000168	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FOXO3—salivary gland cancer	1.4e-05	0.000167	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—VCAN—salivary gland cancer	1.4e-05	0.000166	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	1.37e-05	0.000163	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOTCH1—salivary gland cancer	1.35e-05	0.000161	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—CREBBP—salivary gland cancer	1.35e-05	0.000161	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PYGB—salivary gland cancer	1.35e-05	0.00016	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOTCH1—salivary gland cancer	1.34e-05	0.000159	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOTCH1—salivary gland cancer	1.33e-05	0.000158	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	1.32e-05	0.000157	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CREBBP—salivary gland cancer	1.31e-05	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CDH1—salivary gland cancer	1.3e-05	0.000155	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—PIK3CA—salivary gland cancer	1.26e-05	0.00015	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTEN—salivary gland cancer	1.25e-05	0.000149	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AQP1—salivary gland cancer	1.24e-05	0.000148	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CREBBP—salivary gland cancer	1.23e-05	0.000146	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.23e-05	0.000146	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—salivary gland cancer	1.22e-05	0.000145	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CREBBP—salivary gland cancer	1.21e-05	0.000144	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CREBBP—salivary gland cancer	1.2e-05	0.000143	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EP300—salivary gland cancer	1.19e-05	0.000142	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—HRAS—salivary gland cancer	1.19e-05	0.000142	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—HRAS—salivary gland cancer	1.17e-05	0.000139	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.17e-05	0.000139	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NUP62—salivary gland cancer	1.16e-05	0.000139	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—VCAN—salivary gland cancer	1.15e-05	0.000137	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAP2K2—salivary gland cancer	1.14e-05	0.000136	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	1.14e-05	0.000136	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—PIK3CA—salivary gland cancer	1.14e-05	0.000135	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PHGDH—salivary gland cancer	1.1e-05	0.000131	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—PIK3CA—salivary gland cancer	1.09e-05	0.00013	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	1.06e-05	0.000126	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HRAS—salivary gland cancer	1.05e-05	0.000125	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HRAS—salivary gland cancer	1.01e-05	0.00012	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CREBBP—salivary gland cancer	1.01e-05	0.00012	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NUP62—salivary gland cancer	9.86e-06	0.000117	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—VCAN—salivary gland cancer	9.78e-06	0.000116	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AQP1—salivary gland cancer	9.6e-06	0.000114	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PTEN—salivary gland cancer	9.38e-06	0.000112	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOTCH1—salivary gland cancer	9.37e-06	0.000112	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—EP300—salivary gland cancer	9.18e-06	0.000109	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCND1—salivary gland cancer	9.08e-06	0.000108	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EP300—salivary gland cancer	8.95e-06	0.000106	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CREBBP—salivary gland cancer	8.86e-06	0.000105	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PIK3CA—salivary gland cancer	8.83e-06	0.000105	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTEN—salivary gland cancer	8.77e-06	0.000104	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.77e-06	0.000104	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTEN—salivary gland cancer	8.66e-06	0.000103	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	8.58e-06	0.000102	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTEN—salivary gland cancer	8.58e-06	0.000102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CREBBP—salivary gland cancer	8.49e-06	0.000101	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EP300—salivary gland cancer	8.36e-06	9.95e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.36e-06	9.95e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EP300—salivary gland cancer	8.26e-06	9.83e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EP300—salivary gland cancer	8.19e-06	9.75e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HRAS—salivary gland cancer	8.17e-06	9.73e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NUP62—salivary gland cancer	7.61e-06	9.06e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—VCAN—salivary gland cancer	7.55e-06	8.99e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PIK3CA—salivary gland cancer	7.24e-06	8.62e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTEN—salivary gland cancer	7.19e-06	8.56e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EP300—salivary gland cancer	6.86e-06	8.16e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PIK3CA—salivary gland cancer	6.79e-06	8.09e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HRAS—salivary gland cancer	6.7e-06	7.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PIK3CA—salivary gland cancer	6.62e-06	7.88e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—salivary gland cancer	6.57e-06	7.82e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTEN—salivary gland cancer	6.33e-06	7.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HRAS—salivary gland cancer	6.28e-06	7.48e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCND1—salivary gland cancer	6.28e-06	7.48e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PIK3CA—salivary gland cancer	6.18e-06	7.36e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.18e-06	7.36e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	6.13e-06	7.3e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HRAS—salivary gland cancer	6.12e-06	7.29e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PIK3CA—salivary gland cancer	6.11e-06	7.27e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTEN—salivary gland cancer	6.06e-06	7.22e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PIK3CA—salivary gland cancer	6.06e-06	7.21e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EP300—salivary gland cancer	6.03e-06	7.18e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—salivary gland cancer	5.98e-06	7.12e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	5.85e-06	6.96e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EP300—salivary gland cancer	5.78e-06	6.89e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HRAS—salivary gland cancer	5.72e-06	6.81e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HRAS—salivary gland cancer	5.65e-06	6.73e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HRAS—salivary gland cancer	5.6e-06	6.67e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CREBBP—salivary gland cancer	5.47e-06	6.51e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PIK3CA—salivary gland cancer	5.07e-06	6.04e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CREBBP—salivary gland cancer	4.51e-06	5.37e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3CA—salivary gland cancer	4.46e-06	5.31e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	4.33e-06	5.15e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3CA—salivary gland cancer	4.28e-06	5.09e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—salivary gland cancer	4.14e-06	4.93e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HRAS—salivary gland cancer	3.96e-06	4.71e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTEN—salivary gland cancer	3.9e-06	4.65e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CREBBP—salivary gland cancer	3.82e-06	4.55e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EP300—salivary gland cancer	3.72e-06	4.43e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTEN—salivary gland cancer	3.22e-06	3.84e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EP300—salivary gland cancer	3.07e-06	3.66e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.95e-06	3.51e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3CA—salivary gland cancer	2.75e-06	3.28e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTEN—salivary gland cancer	2.73e-06	3.25e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EP300—salivary gland cancer	2.6e-06	3.1e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	2.27e-06	2.71e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EP300—salivary gland cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.49e-06	1.77e-05	CbGpPWpGaD
